Literature DB >> 8001597

Aflatoxin induces depletion of activities of phase I biotransformation enzymes in growing rats.

S Raisuddin1, D Parmar, S I Zaidi, K P Singh, A S Verma, P K Seth, P K Ray.   

Abstract

Aflatoxins are suspected human carcinogens and are also known to possess diverse toxicological activities. In the present communication an attempt has been made to evaluate the effects of aflatoxin B1 (AFB1) on hepatic microsomal drug metabolizing enzymes in growing rats. The weanling rats were exposed to 60, 300 or 600 micrograms AFB1/kg body weight, per os, on alternate days for 4 weeks, in 0.2 ml corn oil. A significant depression in the activities of aryl hydrocarbon hydroxylase (AHH), aniline hydroxylase (AH) and aminopyrene-N-demethylase (AND) was observed at 300 micrograms and 600 micrograms doses of AFB1. However, no significant change was recorded in glutathione-S-transferase (GST) activity and total sulphydryl (SH) content upon AFB1 exposure in weanling rats. Thus, AFB1 appears to have more pronounced effect on the phase I, rather than phase II, biotransformation enzyme system in weanling rats. The depression of drug metabolizing enzymes together with suppression of immunity by AFB1, as reported earlier by us, may increase the susceptibility of the host to toxic chemicals, drugs and infectious agents, particularly during the post-natal period.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8001597     DOI: 10.1007/BF03188837

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  29 in total

1.  VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.

Authors:  R KATO; P VASSANELLI; G FRONTINO; E CHIESARA
Journal:  Biochem Pharmacol       Date:  1964-07       Impact factor: 5.858

2.  Biochemical and pharmacological changes in the rat following chronic administration of morphine nalorphine and normorphine.

Authors:  J COCHIN; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1959-02       Impact factor: 4.030

3.  Transplacental transfer of aflatoxin in humans.

Authors:  D W Denning; R Allen; A P Wilkinson; M R Morgan
Journal:  Carcinogenesis       Date:  1990-06       Impact factor: 4.944

4.  Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.

Authors:  D J Jollow; J R Mitchell; N Zampaglione; J R Gillette
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

Review 5.  Developmental aspects of the hepatic cytochrome P450 monooxygenase system.

Authors:  A H Neims; M Warner; P M Loughnan; J V Aranda
Journal:  Annu Rev Pharmacol Toxicol       Date:  1976       Impact factor: 13.820

6.  Immunosuppressive effects of aflatoxin in growing rats.

Authors:  S Raisuddin; K P Singh; S I Zaidi; B N Paul; P K Ray
Journal:  Mycopathologia       Date:  1993-12       Impact factor: 2.574

7.  Characterization of microsomal aryl hydrocarbon hydroxylase of rat brain.

Authors:  M Das; P K Seth; H Mukhtar
Journal:  J Pharmacol Exp Ther       Date:  1981-01       Impact factor: 4.030

8.  Interaction of aflatoxin B1 metabolites with cellular macromolecules in neonatal rats receiving carcinogen through mother's milk.

Authors:  A Allameh; M Saxena; H G Raj
Journal:  Carcinogenesis       Date:  1989-11       Impact factor: 4.944

9.  Effects of aflatoxin on lymphoid cells of weanling rat.

Authors:  K P Singh; S I Zaidi; A K Saxena; P K Ray
Journal:  J Appl Toxicol       Date:  1990-08       Impact factor: 3.446

Review 10.  Mycotoxins: toxicity, carcinogenicity, and the influence of various nutritional conditions.

Authors:  P M Newberne
Journal:  Environ Health Perspect       Date:  1974-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.